Targeting new therapeutics in transplantation

Associate Professor Kate Garlan is head of the immunopathology laboratory at QIMR Berghofer which focuses on adaptive immune polarisation following allogeneic stem cell transplantation and its influence on graft versus host disease (GVHD)

Read more

Your team is investigating an immunological target to improve stem cell transplantation and to treat GVHD. What can you tell us about the research to date? This is a new project and collaboration between me and Professor Christian Engwerda, who leads the Immunology and Infection Laboratory and is Head of the Infectious Diseases program at ...

Already a member?

Login to keep reading.

© 2021 the limbic